These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 11120988
1. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae. Depardieu F, Courvalin P. Antimicrob Agents Chemother; 2001 Jan; 45(1):319-23. PubMed ID: 11120988 [Abstract] [Full Text] [Related]
2. Paradoxical High-Level Spiramycin Resistance and Erythromycin Susceptibility due to 23S rRNA Mutation in Streptococcus constellatus. Capitaine A, Woerther PL, Auzou M, Chachaty E, Guérin F, Giard JC, Cattoir V, Isnard C. Microb Drug Resist; 2020 Jul; 26(7):727-731. PubMed ID: 32031922 [Abstract] [Full Text] [Related]
3. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Tait-Kamradt A, Davies T, Cronan M, Jacobs MR, Appelbaum PC, Sutcliffe J. Antimicrob Agents Chemother; 2000 Aug; 44(8):2118-25. PubMed ID: 10898684 [Abstract] [Full Text] [Related]
4. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Canu A, Malbruny B, Coquemont M, Davies TA, Appelbaum PC, Leclercq R. Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122 [Abstract] [Full Text] [Related]
5. In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations. Farrell DJ, Morrissey I, Bakker S, Buckridge S, Felmingham D. Antimicrob Agents Chemother; 2004 Aug; 48(8):3169-71. PubMed ID: 15273142 [Abstract] [Full Text] [Related]
6. [Resistance to macrolides, lincosamides and streptogramins in infections by Streptococcus pneumoniae]. Alonso Manzanares MA, Gutíerrez Zufiaurre MN, Muñoz Bellido JL, García-Rodríguez JA. Med Clin (Barc); 1998 Feb; 110 Suppl 1():25-30. PubMed ID: 9717157 [No Abstract] [Full Text] [Related]
14. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004). Wierzbowski AK, Nichol K, Laing N, Hisanaga T, Nikulin A, Karlowsky JA, Hoban DJ, Zhanel GG. J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477 [Abstract] [Full Text] [Related]
15. Predominance of 23S rRNA mutants among non-erm, non-mef macrolide-resistant clinical isolates of Streptococcus pneumoniae collected in the United States in 1999-2000. Davies TA, Bush K, Sahm D, Evangelista A. Antimicrob Agents Chemother; 2005 Jul; 49(7):3031-3. PubMed ID: 15980393 [Abstract] [Full Text] [Related]
16. Heterogeneous macrolide resistance and gene conversion in the pneumococcus. Wolter N, Smith AM, Farrell DJ, Klugman KP. Antimicrob Agents Chemother; 2006 Jan; 50(1):359-61. PubMed ID: 16377711 [Abstract] [Full Text] [Related]
19. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Johnston NJ, De Azavedo JC, Kellner JD, Low DE. Antimicrob Agents Chemother; 1998 Sep; 42(9):2425-6. PubMed ID: 9736575 [Abstract] [Full Text] [Related]